Milkybiotics - Boosting Gut Health
.png)
VALUE PROPOSITION
Bovine colostrum and its derived component, IgG have been shown to alter the gut cell surface by increasing the number of attachment sites for health promoting bacteria, leading to increased colonisation in vitro, hence identifying a new application for whey colostrum, and its components. This composition is obtained by removal of fat and caseins and can be further enriched in Immunoglobulin G, the active component.
OPPORTUNITY
HThere is an opportunity for producers of dairy and bioactive ingredients, primarily for the infant formula industry but also ingredient mamufacturers for disease treatment/prevention, to partner with Teagasc to commercialise this IP.
DEVELOPMENT STAGE
A patent application was filed by Teagasc in 2017 which claims novel enriched compositions, based on whey colostrum
ADVANTAGES
- This composition may improve the discrepancy of Bifidobacterium counts found between breast-fed and formula-fed infants through supplementation in infant formula and/or toddler supplements.
- It may also have potential in treating/ preventing diseases associated with lower counts of commensal bacteria eg inflammatory bowel diseases (Crohn’s disease, IBS, periodontal disease, rheumatoid arthritis, atherosclerosis, allergy, multi-organ failure, asthma, and allergic diseases.
.png)